16 August 2018 08:25:07 AM

Mediclinic International appoints a new Director

- 2017-10-03 02:54:10 PM

Mediclinic International Plc announced that Dr Felicity A. H. Harvey CBE is to join its Board as an Independent Non-Executive Director and an additional member of the Clinical Performance and Sustainability Committee with effect from 3 October 2017.

Dr Edwin Hertzog, Chairman of Mediclinic, commented, “The Board is delighted to welcome Dr Harvey as a Non-Executive Director of the company and a member of the Clinical Performance and Sustainability Committee. Her thorough knowledge of the health sector as well as her broad general experience will be a valuable addition to the Board.” 

Dr Harvey is a visiting professor at the Institute of Global Health Innovation, Imperial College London; a non-executive director of Guy’s and St Thomas’ NHS Foundation Trust, London; a trustee of Royal Trinity Hospice, London; a member of the United Nations’ Secretary General’s Global Health Crises Task Force; and a member of the WHO Independent Oversight & Advisory Committee for Health Emergencies. Previously, she was Director-General of Public and International Health at the UK Department of Health; Director of the UK Prime Minister’s Delivery Unit; Head of the Medicines, Pharmacy and Industry Group at the Department of Health; Director of Prison Health at Her Majesty’s Prison Service; Head of Quality Management at NHS Executive; and Private Secretary to the Chief Medical Officer. Dr Harvey qualified in medicine in 1980, is an Honorary Fellow of the Royal College of Physicians and a Fellow of the Faculty of Public Health. She has an international MBA from Henley Management College, and gained further qualifications in clinical microbiology.

There are no disclosures required pursuant to paragraphs (1) to (6) of LR 9.6.13 R of the UK Listing Authority's Listing Rules in respect of this appointment. Dr Harvey’s fees will amount to £66,600 per annum, in-line with current independent non-executive directors.

Following Dr Harvey’s appointment to the Board, the Clinical Performance and Sustainability Committee will continue to be chaired by Dr Edwin Hertzog and its members will comprise Dr Felicity Harvey, Nandi Mandela, Danie Meintjes and Prof Dr Robert Leu.